Firefly BioWorks, Inc. (Cambridge, MA) has developed FirePlex® miRSelect, a customizable microRNA detection platform for rapid profiling of diverse biological samples. The FirePlex® advantage lies in its streamlined, high-throughput protocol, affordable customization, and low capital cost. FirePlex® miRSelect readout is performed on standard flow cytometers, and is offered as a service for users with limited access to flow instruments.